https://www.selleckchem.com/pr....oducts/sumatriptan.h
The median pre-INR of both the TP and T-S/D cohorts was 1.9, with a similar decrease in INR of 0.2 and 0.3 (p = 0.36), respectively, post plasma transfusion. There was no difference in correction of PT/aPTT, mortality, transfusion reactions, readmission rates, length of stay, or inpatient deep venous thrombosis. The median volume of T-S/D plasma transfused for the first dose was 126 mL less than TP (p = .0001). T-S/D was as efficacious as TP for the treatment of coagulopathies and the reversal of coagulation laboratory values. T-S/D
Like
Comment
Share
